Authors
Latest:
Exploring the Diagnostics of Urticaria at ACAAISession at the American College of Allergy, Asthma and Immunology (ACAAI) 2023 Annual Scientific Meeting explored issues in understanding and testing for physical urticaria.
Latest:
Kim Papp, MD, PhD, FRCPC: Exploring the Potential of ESK-001 in Plaque PsoriasisPapp shared insights from the recent STRIDE phase 2 trial, which met all its primary and secondary endpoints. Data was presented at the American Academy of Dermatology Annual Meeting.
Latest:
Case 2: Male, 23 Years OldAn expert in dermatology presents the case of a 23-year-old male patient presenting with unstable vitiligo. He delves into treatment options available for managing this condition, shedding light on the nuances and optimal scenarios for each therapeutic agent.
Latest:
Late-Breaking Data: Upadacitinib for Vitiligo Achieves Skin Repigmentation Through Week 52Iltefat Hamzavi, MD, reviews late-breaking data at AAD on upadacitinib as monotherapy.
Latest:
Does diet really play a role in acne?For years, teenagers have been told to avoid certain foods to reduce acne. A review article examines the evidence.
Latest:
An Overview of ArgyriaArgyria is a rare dermatologic condition that presents with blue or grey mucocutaneous discoloration following cutaneous exposure or ingestion of silver.
Latest:
Managing aBCC and aCSCC With Cemiplimab: Tips From Matthew Reynolds, PA-CReynolds discussed what attendees need to know about using cemiplimab to target their difficult skin cancer patients at the Fall Clinical Dermatology Conference for PAs and NPs.
Latest:
Looking Ahead: A Conversation Surrounding Closing the Gaps in Plaque Psoriasis ManagementDrs Lisa Swanson and Robert J. Casquejo express their optimism for the future of plaque psoriasis management, sharing their vision for expanded treatment approvals in the pediatric population affected by this condition.
Latest:
Late-Breaking Data: Long-Term Safety and Efficacy of Delgocitinib Cream for Chronic Hand EczemaMelinda Gooderham, MSc, MD, FRCPC, provided insights into the significance of the DELTA 3 extension data presented at AAD 2024.
Latest:
Telehealth in 2023: What Physicians Need to KnowAnswers to some common questions about providing telehealth services in 2023.
Latest:
Final Thoughts on Tapinarof in AD Clinical TrialsRaj Chovatiya, MD, PhD, and Adelaide A. Hebert, MD, FAAD, review the study results for the ADORING 1 and ADORING 2 trials, as well as share closing thoughts on the use of tapinarof in management of AD.
Latest:
Glynis Ablon, MD, Previews IMCAS World Congress 2024Ablon’s session highlights include best practices for hair restoration.
Latest:
Shedding LITE on At-Home Phototherapy Treatment for PsoriasisGet a sneak peek ahead of AAD about the LITE study’s patient-centered design, routine care integration, and diverse participant inclusion, offering a cost-effective option in psoriasis treatment.
Latest:
Amy S. Paller, MD: PEDISTAD Trial Explores Bone Health in Children With Atopic DermatitisPaller shares early findings from the award winning poster on PEDISTAD trial and its clinical implication for children with atopic dermatitis.
Latest:
Catching Up With Karan Lal, DO, MS FAADIn between sessions, Lal shared his favorite pearls from AAD, a recent challenging pediatric case in his practice, the significance of LinkedIn, and more.
Latest:
Expert Perspectives on BOLT clinical trial dataJohn Strasswimmer, MD, PhD comments on the impressive utility of both vismodegib and sonidegib in patients with advanced basal cell carcinoma and Jonathan S Zager, MD, FACS, FSSO provides his insight into the clinical utility of both of these treatments.
Latest:
Considerations to Best Serve Transgender Patients Seeking Aesthetic CareRonda Farah, MD, and her colleagues reviewed how dermatology providers play an important role in transgender aesthetic care.
Latest:
Case 2: Expert Opinions on Enhancing Patient Education of Vitiligo Treatment Risks and BenefitsBenjamin Lockshin, MD, FAAD, summarizes the panel's best practices for improving patient education on the risks and benefits of vitiligo treatment. He underscores the importance of establishing and managing expectations for treatment response.
Latest:
Hilary Baldwin, MD, Discusses Impacts of Isotretinoin UseBaldwin reviewed inflammatory bowel disease, depression, and pregnancy during the 2023 ARM Yourself With Knowledge webinar.
Latest:
Topical Remetinostat Effective, Tolerable in Basal Cell CarcinomaThe topical HDAC inhibitor remetinostat demonstrated favorable tolerability and clinically significant efficacy in reducing disease burden in patients with basal cell carcinoma, according to results from a phase 2 trial.
Latest:
Tax-Loss Harvesting: An Important Tactic Every Dermatologist Should ConsiderTo properly execute loss harvesting and reinvestment properly, without running afoul of Internal Revenue Service rules, it is crucial that one works with a professional adviser experienced in these matters.
Latest:
Patient Case #3: 32-Year-Old Male With ADExpert dermatologists review a final case about a 32-year-old male with AD, highlighting systemic therapy as first-line treatment.
Latest:
Severity of Psoriatic Disease Significantly Associated With Risk of Inflammatory Bowel DiseaseA recent study identified an association between psoriasis severity and IBD, Crohn disease, and ulcerative colitis.
Latest:
Tips for Difficult to Control Chronic Spontaneous UrticariaAmanda L. Michaud, PA-C, shares insights on difficult to control chronic spontaneous urticaria at the ACAAI Annual Scientific Meeting.
Latest:
New Long-Term KEYNOTE-716 Data Presented at ASCO 2023Principal investigator Jason Luke, MD, discusses what the new data means for melanoma treatment moving forward.
